News Coverage 11.06.19 Share on Twitter Share on Facebook Share on LinkedIn Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach Related Announcement PICI Welcomes New UCSF Center Director Announcement New Staff Members Join PICI Announcement PICI Members and Partners Featured at #CARTCR